Patrick Plewman - 19 Aug 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Reporting relationship: SVP for Diagnostic Services
Issuer ticker: DGX
Reported as of: 19 Aug 2025
Net transaction value: -$829,356
SEC form: 4
Accepted by SEC: 21 Aug 2025, 16:34:05 UTC
Prior SEC filing: 19 Aug 2025
Next SEC filing: 25 Aug 2025
Source filing: View source filing
Reporting owner signature: Sean D. Mersten, Attorney in Fact for Patrick Plewman

Key filing fact

Patrick Plewman filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 21 Aug 2025.

Key facts

This page summarizes Patrick Plewman's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 21 Aug 2025, 16:34.

Change

Previous filing in this sequence was filed on 19 Aug 2025.
Current net transaction value: -$829,356.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001497368 Primary reporting owner

Plewman Patrick

Relationship: SVP for Diagnostic Services
Address: 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS
Signature: Sean D. Mersten, Attorney in Fact for Patrick Plewman
Signature date: 21 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DGX transaction

Common Stock

Options Exercise

Transaction value: $508,354
Shares: +4,532
Change %: +26%
Price: $112.17
Shares after: 21,776
Date: 19 Aug 2025
Ownership: Direct
Footnotes: F1

DGX transaction

Common Stock

Sale

Transaction value: $829,356
Shares: -4,532
Change %: -21%
Price: $183.00
Shares after: 17,244
Date: 19 Aug 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DGX transaction Derivative

Non-Qualifed Stock Option (right to buy)

Options Exercise

Transaction value: $508,354
Shares: -4,532
Change %: -100%
Price: $112.17
Shares after: 0
Date: 19 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,532
Exercise price: $112.17
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Footnote F2

The options vested in three annual installments beginning with the first on February 18, 2021, the second on February 18, 2022 and the final on February 18, 2023.